This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Tufts University, Kaiser Permanente and several other healthcare organizations recently launched the Food is Medicine National Network of Excellence. The network aims to develop, assess and share the best practices in the food-is-medicine space.
Why haven’t more employers addressed the rising costs of employee healthcare with value-based care? This has to be upsetting to employers experiencing riding employee healthcare costs. The answer may be in offering a value-based healthcare model. Prescription drugs costs are just a small part of healthcare costs (11%).
A new industry survey from the Biotechnology Innovation Organization (BIO) highlights the vulnerability of supply that proposed tariffs would put on medicines, and its impact on patient access. This makes supply of medicines vulnerable especially to proposed tariffs on the EU, China, and Canada, according to BIO.
With its new handheld ultrasound device, Exo is seeking to take point-of-care ultrasound beyond just the emergency medicine field — into areas like urgent care, primary care and the home.
The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).
By neglecting to address prevention as the primary focus of healthcare, we are failing our patients, and we are failing ourselves. Despite the American Academy of Sleep Medicine ’s recent “Defend your Sleep” and “Sleep is Good Medicine” campaigns, most of my patients have never been educated in sleep hygiene.
Maintaining high standards of patient care in the healthcare scene of today depends on operational efficiency and exact administration of medical devices. Leading change in these processes is virtual reality (VR), which provides creative ideas for fleet management of medical equipment and operational optimization in healthcare.
The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.
Our Senior Marketing Strategist, Kathy Gaughran, recently shared invaluable insights at the 2024 Mental Health Marketing (MHM) conference about how to reach consumers during their healthcare journey. We invite you to subscribe to our blog and connect with us on LinkedIn: Stewart Gandolf , Kathy Gaughran , and Healthcare Success.
This four-day annual event brings together healthcare companies from all over Taiwan and the rest of the world. It is also an opportunity for tech companies not typically associated with healthcare, such as ASUS, Intel, and BenQ, to showcase what they’re doing in medicine and healthcare.
Healthcare consumerism has drastically changed the way healthcare professionals need to market and deliver their services. Today’s consumers expect a healthcare experience as innovative and digitally advanced as any other industry. Think of all the reasons someone might decide to switch healthcare providers: . Relocation.
One in three GoFundMe campaigns is now for healthcare-related costs, and it’s getting worse. The passage of the Inflation Control bill is an excellent first step in limiting high drug costs, but our healthcare system is still built for profit at the expense of patients. According to a 2021 study , 1.1
Amazon’s ambitious plan to disrupt the healthcare category seems to have had a course correction after the online retail giant announced it plans to shut down its telehealth service Amazon Care. The post Amazon healthcare push shifts with closure of telehealth service appeared first on.
FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Some, 250,000 child deaths per year can be attributed to counterfeit malaria and pneumonia medicines. The prevalence of fake drugs is a continually growing problem worldwide.
In the post-pandemic landscape, the healthcare industry won’t be able to maintain care quality and protect patient access without strong collaboration between these two parties, health system leaders said during a virtual panel. Even though providers and payers don’t always get along, they need to come together now more than ever.
Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.
From AI-powered insights to the rise of precision medicine, new trends are reshaping the way we connect with patients and healthcare providers. Precision Medicine: Targeting the Right Audience Precision medicine, with its focus on individualized treatment, offers a goldmine of opportunities for marketers.
The joint Big Data Steering Group of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) has published a third workplan, setting actions to be delivered by 2025. According to EMA, the new plan will further enhance the efficient integration of data analysis into the regulatory evaluation of medicinal products.
The AI in Healthcare Virtual Summit focused on AI methods and tools that are set to transform healthcare, medicine, and diagnostics along with the latest applications within the industry. . One example of this is through personalizing medicine, which entails learning about and responding to a patient’s unique condition.
A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). The EMA highlighted that advances in technology such as artificial intelligence (AI) has created opportunities to transform medicine development and regulation.
New analysis from Teva Pharmaceuticals Europe has reported concerning statistics regarding the security of critical medicines supply in the region is at risk. For instance, in the EU, 46 percent of generic medicines from the EU Critical List of Medicines are provided by a single supplier.
The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare. Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy.
healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.
Healthcare professionals are also catching up to the patient group, which has long been engaged on social media. Patient and healthcare professionals anticipate personalized, communication based on value. Nowadays, a lot of healthcare professionals prefer digital updates that are timely and pertinent.
AI is increasingly being used in healthcare to reduce clinician workloads and improve patient outcomes. Ultimately, AI has the potential to revolutionize medical imaging and improve healthcare outcomes around the world. Tell us about yourself – your background and how you got to where you are today at GE Healthcare.
billion saved in healthcare expenditures. The study found that if certain adults received medically-tailored meals, about 1.6 million hospitalizations would have been avoided, resulting in $38.7 Programs to provide these meals would have cost $24.8 billion, leading to $13.6 billion in net savings, according to the report.
By capitalizing on AI advancements, pushing the boundaries of personalized medicine with theranostics, and strengthening digital healthcarenetworks, radiopharmaceuticals are poised to transform healthcare from a reactive to a proactive discipline.
As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and life sciences spaces.
With soaring healthcare spending and poor health outcomes posing significant challenges, the healthcare industry is crying out for higher-value care. Health plans can utilize these resources to navigate the turbulent waters of healthcare cost and quality, ultimately enhancing overall outcomes. What is it?
It is too soon to say if the healthcare industry is on the verge of adopting a retail-style customer focus, however, if we learned anything from the pandemic, it is that patients now realize so much more is possible. How will healthcare respond? The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products.
and telesurgery, and their profound impact on the future of healthcare. We discuss effective strategies for breaking into the industry, emphasizing the importance of professional networking and continuous learning. Discover the advancements in surgical robotics, including the potential of A.I. Dr. McMahon completed an Executive M.B.A.
A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.
And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Sharing data to find the right diagnosis.
Food as Medicine (FaM), also referred to as ‘Food Is Medicine’ or ‘Food Is Health,’ is playing a significant role in the ever-evolving healthcare landscape. Proposed federal and state legislation may soon open additional revenue opportunities for FaM companies in this rapidly growing sector of healthcare.
The 2022-2026 workplan of the initiative Accelerating Clinical Trials in the EU ( ACT EU ) has been published by the European Commission (EC), Heads of Medicines Agencies (HMA) and European Medicines Agency (EMA).
A 2023 report by the Alliance for Regenerative Medicine identified skills gaps in analytical development and testing, quality control, and manufacturing of cell and gene therapies 3 a gap which is expected to widen in the coming years. Internet] Alliance for Regenerative Medicine. References 1. Tomtishen J. 2023; 29:SP4278.
Food as Medicine (FaM), also referred to as ‘Food Is Medicine’ or ‘Food Is Health,’ is playing a significant role in the ever-evolving healthcare landscape. Proposed federal and state legislation may soon open additional revenue opportunities for FaM companies in this rapidly growing sector of healthcare.
Results from the Phase III VISION study have shown the significance of this precision medicine for patients with advanced prostate cancer and it is encouraging to see such innovations being recognised by the MHRA with this licensing authorisation.”. Healthcare professionals are asked to report any suspected adverse events. Pluvicto ®
The European Medicines Agency (EMA) has published a report summarising the mid-point achievements of its Regulatory Science Strategy (RSS) to 2025. Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products.
ViiV Healthcare and the Medicines Patent Pool (MPP) have signed a new voluntary licensing agreement to increase access to cabotegravir long-acting (LA) for HIV pre-exposure prophylaxis (PrEP) in least developed, low-income, lower middle-income and Sub-Saharan African countries.
The scheme aims to support UK advanced therapy medicinal product (ATMP) clinical trials. Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. What key solutions will the investment in the Advanced Therapy Treatment Centre Network provide?
CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. million – making it the most expensive medicine in the world – which was above the $2.9 CSL launched the therapy in the US with a list price of $3.5
Discover the AI methods & tools set to revolutionize healthcare, medicine & diagnostics, as well as industry applications and key insights at our AI in Healthcare Virtual Summit. This is a 2 in 1 online summit about the advancements and implementations of healthcare in AI. Get your ticket and find out more today!
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content